Crescent Biopharma, Inc.
CBIO
$18.00
$0.724.17%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 189.16M | 213.19M | 133.27M | 152.65M | 22.43M |
| Total Receivables | -- | 18.00M | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.40M | 5.46M | 1.30M | 1.58M | 409.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 195.56M | 236.66M | 134.56M | 154.23M | 22.84M |
|
|
|||||
| Total Current Assets | 195.56M | 236.66M | 134.56M | 154.23M | 22.84M |
| Net Property, Plant & Equipment | 2.30M | 2.32M | 2.35M | 1.80M | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.27M | 1.32M | 1.36M | 1.41M | 2.77M |
| Total Assets | 199.13M | 240.29M | 138.27M | 157.43M | 25.61M |
|
|
|||||
| Total Accounts Payable | 1.19M | 10.00M | 2.56M | 1.65M | 634.00K |
| Total Accrued Expenses | 4.43M | 8.48M | 15.24M | 12.79M | 12.78M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 453.00K | 435.00K | 417.00K | 211.00K | -- |
| Total Finance Division Other Current Liabilities | 8.12M | 17.16M | 2.09M | 2.10M | 874.00K |
| Total Other Current Liabilities | 8.12M | 17.16M | 2.09M | 2.10M | 874.00K |
| Total Current Liabilities | 14.19M | 36.07M | 20.30M | 16.75M | 14.28M |
|
|
|||||
| Total Current Liabilities | 14.19M | 36.07M | 20.30M | 16.75M | 14.28M |
| Long-Term Debt | -- | -- | -- | -- | 37.48M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.09M | 1.21M | 1.32M | 1.43M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 15.28M | 37.28M | 21.63M | 18.18M | 51.77M |
|
|
|||||
| Common Stock & APIC | 374.94M | 370.82M | 192.05M | 190.06M | 2.85M |
| Retained Earnings | -195.09M | -171.81M | -79.41M | -54.81M | -33.02M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 179.85M | 199.01M | 112.64M | 135.25M | -30.16M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 4.00M | 4.00M | 4.00M | 4.00M | 4.00M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 4.00M | 4.00M | 4.00M | 4.00M | 4.00M |
|
|
|||||
| Total Common Equity | 179.85M | 199.01M | 112.64M | 135.25M | -30.16M |
| Total Preferred Equity | 4.00M | 4.00M | 4.00M | 4.00M | 4.00M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 183.85M | 203.01M | 116.64M | 139.25M | -26.16M |
|
|
|||||